Substrate
Topic

life-sciences

5 stories related to this topic, newest first.

Harvard and MIT Professor Discusses AI and Life Sciences in Healthcaremanilatimes.net
ai16 days ago

Harvard and MIT Professor Discusses AI and Life Sciences in Healthcare

George Church, a professor at Harvard and MIT, spoke about artificial intelligence and life sciences advances. The remarks were delivered at an America250 and Forbes event focused on innovation.

FO
1 source
Ginkgo Bioworks to Close Traditional Labs and Spin Off Biosecurity Unitprnewswire.com
technology20 days ago

Ginkgo Bioworks to Close Traditional Labs and Spin Off Biosecurity Unit

The Boston company reported cumulative net losses of $6 billion since 2020 and a 24 percent revenue decline last year. It will focus on selling AI-driven lab robots to drug companies and universities while offering cloud access to automated experiments. The company already operat…

The Boston Globe
1 source
China Ranks Third in Global AI Competitiveness Index for Life SciencesSouth China Morning Post
ai22 days ago

China Ranks Third in Global AI Competitiveness Index for Life Sciences

China placed third in the latest Global AI Competitiveness Index for biotechnology, healthcare and longevity with a score of 85.3. The index was released on May 11, 2026 by Deep Knowledge Group. Hong Kong ranked third among city-level innovation hubs.

South China Morning Post
1 source
Arcera and Fosun Pharma Sign MoU to Boost Innovation in China and UAESubstrate placeholder — needs review
finance35 days ago

Arcera and Fosun Pharma Sign MoU to Boost Innovation in China and UAE

Arcera and Fosun Pharma have executed a memorandum of understanding in Shanghai, China. The agreement, signed by key executives, aligns with strategic partnerships between China and the UAE. It aims to create pathways for innovation and market access in both nations.

Benzinga
1 source
OpenAI Releases GPT-Rosalind, AI Model Tailored for Biology and Drug DiscoverySubstrate placeholder — needs review
ai46 days ago

OpenAI Releases GPT-Rosalind, AI Model Tailored for Biology and Drug Discovery

OpenAI announced GPT-Rosalind, an artificial intelligence model designed for research in biology, drug discovery, and translational medicine. The model is named after scientist Rosalind Franklin and targets scientific workflows involving molecules, proteins, and disease biology.…

Euronews
New York Post
GG
FO
TechCrunch
+9
14 sources